Gulsen Kama - 18 Sep 2023 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: Chief Financial Officer
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol: BNGO
Transactions as of: 18 Sep 2023
Net transactions value: $0
Form type: 4
Filing time: 20 Sep 2023, 17:21:59 UTC
Previous filing: 20 Sep 2023
Next filing: 05 Jun 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNGO	Stock Option (Right to Buy)	Award	$0	+106,000		$0.000000	106,000	18 Sep 2023	Common Stock	106,000	$3.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the option shall vest and become exercisable on September 11, 2024, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from September 11, 2024, subject to Reporting Person's Continuous Service (as defined in the Company's 2020 Inducement Plan, as amended) through each such applicable vesting date and the terms of the Company's 2020 Inducement Plan, as amended.

Content

25% of the shares subject to the option shall vest and become exercisable on September 11, 2024, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from September 11, 2024, subject to Reporting Person's Continuous Service (as defined in the Company's 2020 Inducement Plan, as amended) through each such applicable vesting date and the terms of the Company's 2020 Inducement Plan, as amended.